Cargando…
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
Invasive lobular carcinoma (ILC) represents the second most common subtype of breast cancer (BC), accounting for up to 15% of all invasive BC. Loss of cell adhesion due to functional inactivation of E-cadherin is the hallmark of ILC. Although the current world health organization (WHO) classificatio...
Autores principales: | De Schepper, Maxim, Vincent-Salomon, Anne, Christgen, Matthias, Van Baelen, Karen, Richard, François, Tsuda, Hitoshi, Kurozumi, Sasagu, Brito, Maria Jose, Cserni, Gabor, Schnitt, Stuart, Larsimont, Denis, Kulka, Janina, Fernandez, Pedro Luis, Rodríguez-Martínez, Paula, Olivar, Ana Aula, Melendez, Cristina, Van Bockstal, Mieke, Kovacs, Aniko, Varga, Zsuzsanna, Wesseling, Jelle, Bhargava, Rohit, Boström, Pia, Franchet, Camille, Zambuko, Blessing, Matute, Gustavo, Mueller, Sophie, Berghian, Anca, Rakha, Emad, van Diest, Paul J., Oesterreich, Steffi, Derksen, Patrick W. B., Floris, Giuseppe, Desmedt, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708574/ https://www.ncbi.nlm.nih.gov/pubmed/35922548 http://dx.doi.org/10.1038/s41379-022-01135-2 |
Ejemplares similares
-
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma
por: Christgen, Matthias, et al.
Publicado: (2021) -
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors
por: Christgen, Matthias, et al.
Publicado: (2021) -
Methylation biomarkers for pleomorphic lobular breast cancer - a short report
por: Moelans, Cathy B., et al.
Publicado: (2015) -
Lobular breast cancer: molecular basis, mouse and cellular models
por: Christgen, Matthias, et al.
Publicado: (2015) -
Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2021)